Trastuzumab is indicated for
- Adjuvant Breast Cancer
- Metastatic Breast Cancer
- Gastric Cancer
Bevacizumab is a tumor-starving (anti-angiogenic) therapy. Bevacizumab is designed to block a protein called vascular endothelial growth factor, or VEGF. Bevacizumab is indicated for
- Metastatic Colorectal Cancer (mCRC)
- Non–Small Cell Lung Cancer (nsNSCLC)
- Glioblastoma (GBM)
- Metastatic Kidney Cancer (mRCC)
- Advanced Cervical Cancer (CC)
- Ovarian Cancer (OC)
- Hepatocellular Carcinoma (HCC)
Rituximab is a prescription medicine used to treat:
- Non-Hodgkin’s Lymphoma (NHL)
- Chronic Lymphocytic Leukemia (CLL)
- Rheumatoid arthritis (RA)
- Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)
- Pemphigus Vulgaris (PV)